Analysis of the Domestic General Government Health Expenditure in the United Arab Emirates from 2013 to 2023 shows fluctuating trends. The expenditure as a percentage of GDP decreased consistently from 2013 (2.59%) to 2018 (2.14%). However, since 2019, expenditures have rebounded, particularly in 2020 with a significant jump to 3.46%, likely due to the COVID-19 pandemic. This rising trend continued into 2021 (3.54%) and reached 3.71% in 2023.
Year-on-year growth rates highlight these changes: from a substantial -10.99% drop in 2017 to a robust increase of 54.34% in 2020. The compound annual growth rate (CAGR) from 2018-2023 demonstrates an average yearly growth of 11.66%, indicating a strong recovery and continuous growth in government health expenditure.
Future trends predict an average annual increase of 1.68% from 2024 to 2028, with the total expenditure reaching 4.12% of GDP by 2028. Policymakers should note this steady increase and plan accordingly for sustained enhancements in healthcare infrastructure and services.
Future trends to watch for include the impact of potential economic fluctuations, healthcare reforms, and advancements in medical technology, which could influence government spending patterns significantly.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...